段心雨 韦红
[摘要]万古霉素作为特殊使用级抗菌药物,在重症感染的治疗中发挥着重要作用,是治疗革兰阳性菌严重感染的首选药物,尤其是耐甲氧西林金黄色葡萄球菌感染。新生儿感染性疾病发病率高、病情严重,耐药性革兰阳性菌感染增多,应用万古霉素越来越广泛,但仍存在若干问题。新生儿是特殊群体,肾脏等器官功能发育不成熟,其药物代谢动力学独特,个体差异大,目前给药方案、疗效与安全性等仍有较多未知。近年来万古霉素在新生儿的临床应用得到医药界的高度关注。本文就万古霉素在新生儿感染性疾病中的應用进展作一综述。
[关键词]万古霉素;新生儿;革兰阳性菌;药动学;不良反应
[中图分类号] R969 [文献标识码] A [文章编号] 1674-4721(2020)5(c)-0044-04
Research advances in the application of Vancomycin in neonatal infectious diseases
DUAN Xin-yu WEI Hong
Department of Neonatology, Children′s Hospital of Chongqing Medical University, China Ministry of Education Key Laboratory of Child Development and Disorders, National Clinical Research Center for Child Health and Disorders, China International Science and Technology Cooperation Base of Child development and Critical Disorders, Chongqing Key Laboratory of Pediatrics, Chongqing 400014, China
[Abstract] Vancomycin, as a special-use antibacterial drug, plays an important role in the treatment of severe infections. It is the first choice for critical infections caused by Gram-positive bacteria, especially Methicillin-resistant Staphylococcus aureus infections. The incidence of serious infectious disease is high in newborns and recently Gram-positive bacterial infections are increasing, the application of Vancomycin in pediatrics is becoming more and more widespread, but there are still some problems. Newborns are a special group, whose functions of kidney and other organs are immature, their pharmacokinetics is unique, and the individual differences are significant. At present, the optimal dosing regimen, efficacy and safety of Vancomycin in neonates still lack consensus. In recent years, the clinical application of Vancomycin in neonates has attracted great attention in the medical fields, and this article reviews the advances in the application of Vancomycin in neonatal infectious diseases.
[Key words] Vancomycin; Neonate; Gram-positive bacteria; Pharmacokinetics; Adverse reactions
新生儿感染性疾病严重危害新生儿生命健康,其中新生儿败血症是新生儿发病率和死亡率的主要原因[1-2],尤其是早产儿和低出生体重儿[3]。革兰阳性菌是新生儿重症监护病房感染中最常见的病原菌,如金黄色葡萄球菌、凝固酶阴性葡萄球菌和肠球菌等,其中耐甲氧西林金黄色葡萄球菌(Methicillin-resistant Staphylococcus aureus,MRSA)感染可导致高发病率和死亡率[4]。上述病原菌可引发新生儿严重感染,常常存在多重耐药,万古霉素由于其良好的抗菌活性,被广泛用于疑似或确诊β内酰胺酶耐药革兰阳性菌感染的一线治疗。鉴于万古霉素在新生儿感染治疗中的广泛应用,本文就其临床应用进展作一综述。
1万古霉素结构特点与作……